Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/29336
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
- INI - Artigos de Periódicos [3488]
Metadatos
Mostrar el registro completo del ítem
FREQUENCY AND PREDICTORS OF ESTIMATED HIV TRANSMISSIONS AND BACTERIAL STI ACQUISITION AMONG HIV-POSITIVE PATIENTS IN HIV CARE ACROSS THREE CONTINENTS
Global HIV prevention
Global HIV transmission
Secondary prevention
Treatment as prevention
Autor
Afiliación
The Fenway Institute. Fenway Health. Boston, MA, USA / University of Miami. Department of Psychology. Coral Gables, FL, USA.
Fred Hutchinson Cancer Research Center. Seattle, WA, USA / University of Washington. School of Public Health. Seattle, WA, USA.
The Fenway Institute. Fenway Health. Boston, MA, USA / Brown University. Institute for Community Health Promotion. Providence RI, USA.
FHI360. Durham, NC, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Chiang Mai University. Research Institute for Health Sciences. Chiang Mai, Thailand / Chiang Mai University. Faculty of Medicine. Chiang Mai, Thailand.
Centre for Infectious Disease Research in Zambia. Lusaka, Zambia.
Fred Hutchinson Cancer Research Center. Seattle, WA, USA / University of Washington. School of Public Health. Seattle, WA, USA.
National Institute of Allergy and Infectious Disease. Bethesda, MD, USA.
Department of Pathology. Division of Infectious Diseases. Johns Hopkins School of Medicine. Baltimore, MD, USA / Department of Medicine. Division of Infectious Diseases. Johns Hopkins School of Medicine. Baltimore, MD, USA.
Behavioral Medicine Service. Massachusetts General Hospital. Harvard Medical School. Boston, MA, USA.
Department of Pathology. Division of Infectious Diseases. Johns Hopkins School of Medicine. Baltimore, MD, USA / Department of Medicine. Division of Infectious Diseases. Johns Hopkins School of Medicine. Baltimore, MD, USA.
Department of Epidemiology. Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA.
The Fenway Institute. Fenway Health. Boston, MA, USA / Department of Medicine. Harvard Medical School. Beth Israel Deaconess Medical Center. Boston, MA, USA.
Fred Hutchinson Cancer Research Center. Seattle, WA, USA / University of Washington. School of Public Health. Seattle, WA, USA.
The Fenway Institute. Fenway Health. Boston, MA, USA / Brown University. Institute for Community Health Promotion. Providence RI, USA.
FHI360. Durham, NC, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Chiang Mai University. Research Institute for Health Sciences. Chiang Mai, Thailand / Chiang Mai University. Faculty of Medicine. Chiang Mai, Thailand.
Centre for Infectious Disease Research in Zambia. Lusaka, Zambia.
Fred Hutchinson Cancer Research Center. Seattle, WA, USA / University of Washington. School of Public Health. Seattle, WA, USA.
National Institute of Allergy and Infectious Disease. Bethesda, MD, USA.
Department of Pathology. Division of Infectious Diseases. Johns Hopkins School of Medicine. Baltimore, MD, USA / Department of Medicine. Division of Infectious Diseases. Johns Hopkins School of Medicine. Baltimore, MD, USA.
Behavioral Medicine Service. Massachusetts General Hospital. Harvard Medical School. Boston, MA, USA.
Department of Pathology. Division of Infectious Diseases. Johns Hopkins School of Medicine. Baltimore, MD, USA / Department of Medicine. Division of Infectious Diseases. Johns Hopkins School of Medicine. Baltimore, MD, USA.
Department of Epidemiology. Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA.
The Fenway Institute. Fenway Health. Boston, MA, USA / Department of Medicine. Harvard Medical School. Beth Israel Deaconess Medical Center. Boston, MA, USA.
Resumen en ingles
Introduction: Successful global treatment as prevention (TasP) requires identifying HIV-positive individuals at high risk for transmitting HIV, and having impact via potential infections averted. This study estimated the frequency and predictors of numbers of HIV transmissions and bacterial sexually transmitted infection (STI) acquisition among sexually active HIV-positive individuals in care from three representative global settings. Methods: HIV-positive individuals (n=749), including heterosexual men, heterosexual women and men who have sex with men (MSM) in HIV care, were recruited from Chiang Mai (Thailand), Rio de Janeiro (Brazil) and Lusaka (Zambia). Participants were assessed on HIV and STI sexual transmission risk variables, psychosocial characteristics and bacterial STIs at enrolment and quarterly for 12 months (covering 15 months). Estimated numbers of HIV transmissions per person were calculated using reported numbers of partners and sex acts together with estimates of HIV transmissibility, accounting for ART treatment and condom use. Results: An estimated 3.81 (standard error, (SE)=0.63) HIV transmissions occurred for every 100 participants over the 15 months, which decreased over time. The highest rate was 19.50 (SE=1.68) for every 100 MSM in Brazil. In a multivariable model, country×risk group interactions emerged: in Brazil, MSM had 2.85 (95% CI=1.45, 4.25, p<0.0001) more estimated transmissions than heterosexual men and 3.37 (95% CI=2.01, 4.74, p<0.0001) more than heterosexual women over the 15 months. For MSM and heterosexual women, the combined 12-month STI incidence rate for the sample was 22.4% (95% CI=18.1%, 27.3%; incidence deemed negligible in heterosexual men). In the multivariable model, MSM had 12.3 times greater odds (95% CI=4.44, 33.98) of acquiring an STI than women, but this was not significant in Brazil. Higher alcohol use on the Alcohol Use Disorders Identification Test (OR=1.04, 95% CI=1.01, 1.08) was also significantly associated with increased STI incidence. In bivariate models for both HIV transmissions and STI incidence, higher depressive symptoms were significant predictors. Conclusions: These data help to estimate the potential number of HIV infections transmitted and bacterial STIs acquired over time in patients established in care, a group typically considered at lower transmission risk, and found substantial numbers of estimated HIV transmissions. These findings provide an approach for evaluating the impact (in phase 2 studies) and potentially cost-effectiveness of global TasP efforts.
Palabras clave en ingles
MSMGlobal HIV prevention
Global HIV transmission
Secondary prevention
Treatment as prevention
Compartir